Drug-induced lung disease: 1990 review

Numerous drug-induced pulmonary manifestations have been reported but studies of their pathogenic mechanisms are still rare. These mechanisms should, however, be precisely determined in order to identify subjects at risk and to prevent some of these complications by the proper use of certain drugs in more appropriate conditions. The possibility of an iatrogenic manifestation should always be considered in patients developing pulmonary symptoms. Data from biological investigations, although not specific, contribute to the understanding of lung injury mechanisms.

This article has been cited by other articles:

				H Ohnishi, A Yokoyama, Y Yasuhara, A Watanabe, T Naka, H Hamada, M Abe, K Nishimura, J Higaki, J Ikezoe, et al. Circulating KL-6 levels in patients with drug induced pneumonitis Thorax, October 1, 2003; 58(10): 872 - 875. [Abstract] [Full Text] [PDF]

				J. C.M. Theuws, S. H. Muller, Y. Seppenwoolde, S. L.S. Kwa, L. J. Boersma, G. A.M. Hart, P. Baas, and J. V. Lebesque Effect of Radiotherapy and Chemotherapy on Pulmonary Function After Treatment for Breast Cancer and Lymphoma: A Follow-Up Study J. Clin. Oncol., October 1, 1999; 17(10): 3091 - 3100. [Abstract] [Full Text] [PDF]